Maximus, Inc. (NYSE:MMS) Stake Increased by Dean Investment Associates LLC

Dean Investment Associates LLC boosted its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 58.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 58,644 shares of the health services provider's stock after purchasing an additional 21,650 shares during the period. Dean Investment Associates LLC owned approximately 0.10% of Maximus worth $4,378,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of MMS. UMB Bank n.a. grew its position in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after buying an additional 158 shares during the period. Eastern Bank acquired a new stake in shares of Maximus in the fourth quarter valued at approximately $29,000. V Square Quantitative Management LLC grew its holdings in shares of Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares during the period. R Squared Ltd purchased a new stake in shares of Maximus in the 4th quarter valued at approximately $54,000. Finally, IFP Advisors Inc raised its position in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after purchasing an additional 302 shares during the period. Hedge funds and other institutional investors own 97.21% of the company's stock.

Insider Buying and Selling

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares of the company's stock, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

MMS has been the topic of several research reports. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price on the stock in a research note on Thursday, January 2nd. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.

Maximus Stock Performance

Maximus stock traded up $0.73 during trading hours on Tuesday, reaching $67.63. 92,641 shares of the stock were exchanged, compared to its average volume of 548,434. The stock has a market cap of $3.83 billion, a P/E ratio of 14.56 and a beta of 0.68. The firm's 50 day moving average is $67.60 and its 200 day moving average is $75.01. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.77%. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.